NCT05468541

Brief Summary

A prospective cohort mixed study using both qualitative and quantitative elements. The quantitative component will involve tracking outcomes at baseline and at twelve weeks, using Health of the Nation Outcome Scale for People with a Learning Disability (for quality of life) and Hospital Anxiety and Depression Rating Scale (for anxiety and depression). The qualitative study will involve semi structured interviews with end users to understand usage and acceptability of Brain in Hand app with the added impact of the pandemic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 21, 2022

Completed
Last Updated

July 21, 2022

Status Verified

June 1, 2022

Enrollment Period

5 months

First QC Date

June 22, 2022

Last Update Submit

July 20, 2022

Conditions

Outcome Measures

Primary Outcomes (11)

  • What is the impact of BiH on quality of life over a three-month period?

    The Health of the Nation Outcome Scales for People with Learning Disabilities is measured on a five-point scale (0-4) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared

    3 months

  • What is the impact of BiH on the participant's mental health?

    Hospital Anxiety and Depression Scale is measured on a four-point scale (0-3) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared

    3 months

  • Level of acceptability (drop-out rates)

    Drop out rates will be recorded

    3 months

  • Discover the participant's experience of using BiH App to measure outcomes of reliance on their care support

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

  • Understand how BiH impacts on coping skills

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

  • To gain understanding of how BIH has impacted on the autistic person's ability to manage challenging social situations

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

  • Does BiH App help autistic people feel safe?

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

  • Does the BiH help autistic people feel more independent?

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

  • Can access 24/7 telephone support help autistic people feel self-empowered to manage their anxiety?

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

  • To gain an understanding of how BiH Traffic Light system helps a person manage their anxiety, independence and support their coping skills

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

  • Does the participant believe remote support has improved their access to healthcare during the pandemic?

    Short semi structured interviews with ten end users to understand usage and acceptability

    3 months

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Members of the participant's existing clinical care team will access their patient records and their autism waiting list to identify potential participants for the study with the participation criteria followed without deviation.

You may qualify if:

  • All who have been diagnosed with Autism Spectrum Disorder (ASD) as per DSM-5 criteria level (1) or post screening by health professional such as a GP and on the confirmatory diagnostic pathway.
  • Age ranges from 19 to 80.
  • Participant has been screened by the Columbia Suicide Rating Scale as not having risk concerns of suicide.
  • Access to smart devices with compatibility to running BiH. The Participant will require a Smart Phone and either a Laptop / Tablet / Note Book.
  • Has capacity to give informed consent and can give informed consent.
  • They can understand the BiH information.

You may not qualify if:

  • Any acute or chronic condition, particularly neurodevelopmental conditions such as significant intellectual disability, Level 2/3 DSM V ASD.
  • Diagnosed con-current psychological comorbidity (psychosis, severe depression etc.) that would limit the ability of the participant to take part in the study.
  • Anyone who declines to give consent or are unable to give informed consent. 5. Anyone who has been screened positive with the (C-SSRS) suicide risk scale.
  • \. Not willing to engage with smart device/internet. 7. Insufficient English language to understand and complete questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cornwall Partnership NHS Foundation Trust

Bodmin, Cornwall, PL31 2QN, United Kingdom

Location

MeSH Terms

Conditions

Autistic Disorder

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2022

First Posted

July 21, 2022

Study Start

July 30, 2021

Primary Completion

December 31, 2021

Study Completion

March 31, 2022

Last Updated

July 21, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations